Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc.
Centre Oscar Lambret
Nuvation Bio Inc.
Incyte Corporation
3B Pharmaceuticals GmbH
Elevation Oncology
Seagen Inc.
Tango Therapeutics, Inc.
Pfizer
Medikine, Inc.
OHSU Knight Cancer Institute
Centre Hospitalier Universitaire de Besancon
Rutgers, The State University of New Jersey
pharmaand GmbH
M.D. Anderson Cancer Center
Genmab
MacroGenics
Advanced Accelerator Applications
Scripps Translational Science Institute
University of Wisconsin, Madison
University of Wisconsin, Madison
CureOne
National Institutes of Health Clinical Center (CC)
Maastricht Radiation Oncology
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Cota Inc.
New York State Psychiatric Institute
SWOG Cancer Research Network
Merck Sharp & Dohme LLC
Mirati Therapeutics Inc.
Pfizer
Calando Pharmaceuticals
Auron Healthcare GmbH
Emory University
University of Wisconsin, Madison